UA80872C2 - Фармацевтична композиція, що містить як активну речовину платиновий комплекс, і спосіб її виготовлення - Google Patents
Фармацевтична композиція, що містить як активну речовину платиновий комплекс, і спосіб її виготовленняInfo
- Publication number
- UA80872C2 UA80872C2 UAA200510188A UAA200510188A UA80872C2 UA 80872 C2 UA80872 C2 UA 80872C2 UA A200510188 A UAA200510188 A UA A200510188A UA A200510188 A UAA200510188 A UA A200510188A UA 80872 C2 UA80872 C2 UA 80872C2
- Authority
- UA
- Ukraine
- Prior art keywords
- active substance
- pharmaceutical composition
- platinum complex
- manufacturing
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
- A61K9/5057—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Винахід пов'язаний з фармацевтичною композицією, що містить як активну речовину комплексну сполуку платини за формулою (І), де А, А', В, В', Х і X' мають визначені значення, в суміші з щонайменше одним фармацевтично прийнятним наповнювачем, яка характеризується тим, що формується з гранулята з часточками, розмір яких менший ніж 0,5 мм, виготовленого шляхом вологої грануляції суміші комплексної сполуки чотиривалентної платини за формулою (І), яка змочується водою щонайменше, одного нейтрального сахариду і щонайменше одного природного і/або модифікованого полісахариду, яка на вибір може бути включена в капсули або мішечки чи, при потребі, бути спресована у формі таблеток, причому поверхню гранул, капсул чи таблеток при потребі покривають шаром щонайменше однієї фармацевтично прийнятної речовини, що забезпечує ентеросольвентне розчинення активної речовини лише в кишечнику, і/або щонайменше однієї фармацевтично прийнятної речовини, що забезпечує контрольоване вивільнення активної речовини. Цей винахід пов'язаний також зі способом виробництва вказаної фармацевтичної композиції. EMBED ISISServer (І)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZ2003915A CZ296045B6 (cs) | 2003-03-31 | 2003-03-31 | Farmaceutická kompozice obsahující jako účinnou látku komplex čtyřmocné platiny a způsob její výroby |
CZ2004235A CZ2004235A3 (cs) | 2004-02-12 | 2004-02-12 | Farmaceutická kompozice obsahující jako účinnou látku platinový komplex a způsob výroby této kompozice |
PCT/CZ2004/000017 WO2004087126A1 (en) | 2003-03-31 | 2004-03-30 | Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
UA80872C2 true UA80872C2 (uk) | 2007-11-12 |
Family
ID=33132424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200510188A UA80872C2 (uk) | 2003-03-31 | 2004-03-30 | Фармацевтична композиція, що містить як активну речовину платиновий комплекс, і спосіб її виготовлення |
Country Status (12)
Country | Link |
---|---|
US (1) | US20060063832A1 (uk) |
EP (1) | EP1608358A1 (uk) |
JP (1) | JP2006521300A (uk) |
BR (1) | BRPI0408805A (uk) |
CA (1) | CA2517120C (uk) |
HR (1) | HRP20050902A2 (uk) |
MX (1) | MXPA05010254A (uk) |
NO (1) | NO20054897L (uk) |
RS (1) | RS20050714A (uk) |
RU (1) | RU2343913C2 (uk) |
UA (1) | UA80872C2 (uk) |
WO (1) | WO2004087126A1 (uk) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002060446A1 (en) | 2001-01-29 | 2002-08-08 | Shionogi & Co., Ltd. | Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient |
CZ2004235A3 (cs) * | 2004-02-12 | 2005-08-17 | Pliva-Lachema A. S. | Farmaceutická kompozice obsahující jako účinnou látku platinový komplex a způsob výroby této kompozice |
CZ296459B6 (cs) * | 2004-09-14 | 2006-03-15 | Pliva-Lachema A. S. | Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo |
NZ591443A (en) * | 2005-09-22 | 2013-04-26 | Intermune Inc | Granule formation of pirfenidone and pharmaceutically acceptable excipients |
CZ300590B6 (cs) * | 2006-06-20 | 2009-06-24 | Pliva - Lachema A. S. | Farmaceutická kompozice pro injekcní podání |
EP2223683B1 (en) * | 2007-12-27 | 2014-06-18 | Taiho Pharmaceutical Co., Ltd. | Oral particulate antitumor preparation |
AU2010210593B2 (en) * | 2009-02-04 | 2015-09-03 | The Brigham And Women's Hospital, Inc. | Nanoscale platinum compounds and methods of use thereof |
MX2018006953A (es) | 2015-12-09 | 2019-05-16 | Univ Wien Med | Compuestos de platino funcionalizados con monomaleimida para la terapia del cancer. |
CA2937365C (en) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4302446A (en) * | 1979-10-02 | 1981-11-24 | Bristol-Myers Company | Pharmaceutical compositions |
JPS5970614A (ja) * | 1982-10-14 | 1984-04-21 | Asahi Chem Ind Co Ltd | 微量主薬系湿式固形製剤方法 |
US5240954A (en) * | 1985-06-25 | 1993-08-31 | Glaxo Group Limited | Medicaments |
US5256653A (en) * | 1987-02-19 | 1993-10-26 | Henkel Kommanditgesellschaft Auf Aktien | Pharmaceutical preparations containing platinum complexes/phosphonic acid liquid and processes for their use |
FI905018A0 (fi) * | 1989-10-17 | 1990-10-12 | Bristol Myers Squibb Co | I vatten och loesningsmedel loesliga axiala hydroxi-och mono- och dikarboxylsyraderivat med stor tumoeraktivitet. |
IT1241417B (it) * | 1990-03-06 | 1994-01-14 | Vectorpharma Int | Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione |
IT1246382B (it) * | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon |
FR2729857B1 (fr) * | 1995-01-27 | 1997-04-04 | Rhone Poulenc Chimie | Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire |
JPH10265380A (ja) * | 1997-03-17 | 1998-10-06 | Bristol Myers Squibb Co | 抗ガン剤 |
CZ288912B6 (cs) * | 1998-05-27 | 2001-09-12 | Lachema, A. S. | Komplex platiny v oxidačním čísle IV, způsob přípravy tohoto komplexu, tento komplex jako léčivo a farmaceutická kompozice tento komplex obsahující |
KR100317473B1 (ko) * | 1999-05-11 | 2001-12-22 | 이계호 | 신규의 백금(iv)착제 및 그 제조방법 |
JP2001347153A (ja) * | 2000-06-12 | 2001-12-18 | Asahi Kasei Corp | 錠剤の製造方法 |
-
2004
- 2004-03-30 BR BRPI0408805-0A patent/BRPI0408805A/pt not_active IP Right Cessation
- 2004-03-30 JP JP2006504221A patent/JP2006521300A/ja active Pending
- 2004-03-30 US US10/549,296 patent/US20060063832A1/en not_active Abandoned
- 2004-03-30 CA CA2517120A patent/CA2517120C/en not_active Expired - Fee Related
- 2004-03-30 RS YUP-2005/0714A patent/RS20050714A/sr unknown
- 2004-03-30 UA UAA200510188A patent/UA80872C2/uk unknown
- 2004-03-30 WO PCT/CZ2004/000017 patent/WO2004087126A1/en active Application Filing
- 2004-03-30 RU RU2005133428/15A patent/RU2343913C2/ru not_active IP Right Cessation
- 2004-03-30 MX MXPA05010254A patent/MXPA05010254A/es unknown
- 2004-03-30 EP EP04724245A patent/EP1608358A1/en not_active Withdrawn
-
2005
- 2005-10-17 HR HR20050902A patent/HRP20050902A2/hr not_active Application Discontinuation
- 2005-10-24 NO NO20054897A patent/NO20054897L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2343913C2 (ru) | 2009-01-20 |
MXPA05010254A (es) | 2006-02-22 |
US20060063832A1 (en) | 2006-03-23 |
HRP20050902A2 (en) | 2005-12-31 |
RS20050714A (sr) | 2008-04-04 |
RU2005133428A (ru) | 2006-05-10 |
BRPI0408805A (pt) | 2006-03-28 |
EP1608358A1 (en) | 2005-12-28 |
CA2517120A1 (en) | 2004-10-14 |
WO2004087126A1 (en) | 2004-10-14 |
CA2517120C (en) | 2012-09-18 |
AU2004226898A1 (en) | 2004-10-14 |
NO20054897L (no) | 2005-10-24 |
JP2006521300A (ja) | 2006-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sharma et al. | Low density multiparticulate system for pulsatile release of meloxicam | |
JP5154924B2 (ja) | ジェランガムを含む膨張可能な投与形態 | |
Huang et al. | A novel plug-controlled colon-specific pulsatile capsule with tablet of curcumin-loaded SMEDDS | |
RS20070511A (en) | Modified release pharmaceutical compositions and processes thereof | |
NZ710384A (en) | A novel formulation of indomethacin | |
ES2543427T3 (es) | Forma farmacéutica oral de deferasirox | |
CN1292703A (zh) | 发泡性肠溶制剂 | |
WO2002045684A3 (en) | Rapidly dispersing pharmaceutical composition comprising effervescent agents | |
NO20054897L (no) | Farmasoytisk preparat inneholdende platinakompleks som aktiv substans og fremgangsmate for fremstilling derav | |
WO2008008592A3 (en) | Multi-particulate formulation having tramadol in immediate and controlled release form | |
WO2006041843A3 (en) | Pharmaceutical dosage form comprising meloxicam | |
CN101822673B (zh) | 一种含有伊潘立酮的固体药物组合物 | |
TW201206453A (en) | New use of diatomaceous earth in the pharmaceutical industry | |
ATE230979T1 (de) | Verfahren zur herstellung neuer fenofibrathaltiger arzneiformulierungen, dadurch hergestellte arzneiformulierungen und ihre verwendung | |
CN104706604A (zh) | 一种吡仑帕奈冻干口崩片及其制备方法 | |
DE60212464D1 (de) | Herstellung von tabletten von pharmazeutisch aktiven substanzen mit ungünstigen tablettierungseigenschaften mit einer mikrokristalline zellulose enthaltenden granulierflüssigkeit | |
JP2010163428A (ja) | 崩壊錠 | |
Patel et al. | Ionotropic gelation technique for microencapsulation of antihypertensive drug | |
EA200800833A1 (ru) | Фармацевтическая липидная композиция в виде частиц | |
CN1364464A (zh) | 盐酸氨基葡萄糖药物组合物 | |
MX2009004124A (es) | Nanoparticulas micelares de sustancias quimicas. | |
CN103945832B (zh) | 用于脑能量分子延迟释放和持续释放的组合物,装置及方法 | |
CN101721380A (zh) | 一种制备缓控释制剂的方法 | |
JP2004075594A (ja) | 経口用ウコン類組成物 | |
CN1762354A (zh) | 一种含有钙阻滞剂的稳定药物组合物 |